Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|June 24, 2024
Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 studyRebecca Dent, Javier Cortés, Lajos Pusztai, et al.
The New England Journal of Medicine|September 16, 2024
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast CancerAditya Bardia, Xichun Hu, Rebecca Dent, et al.
Translational Oncology|February 19, 2013
Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastographyOmar Falou, Ali Sadeghi-Naini, Sameera Prematilake, et al.
Annals of Surgical Oncology|February 25, 2026
Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 StudySherko Kuemmel, Peter A Fasching, Peter Schmid, et al.
The Lancet. Oncology|March 7, 2021
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trialEric P Winer, Oleg Lipatov, Seock-Ah Im, et al.
The New England Journal of Medicine|February 27, 2020
Pembrolizumab for Early Triple-Negative Breast CancerPeter Schmid, Javier Cortes, Lajos Pusztai, et al.
JAMA Network Open|November 15, 2023
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialMasato Takahashi, Javier Cortés, Rebecca Dent, et al.
Plos One|September 26, 2019
Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platformYoon-Sim Yap, Man Chun Leong, Yong Wei Chua, et al.
Journal of Clinical Pathology|January 24, 2020
Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHCJoe Yeong, Tira Tan, Zi Long Chow, et al.
European Journal of Cancer (Oxford, England : 1990)|November 17, 2023
Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 studyPeter Schmid, Oleg Lipatov, Seock-Ah Im, et al.
Pageof 8